|
Inovio Pharmaceuticals, Inc.
Ticker Symbol: INO CUSIP: 45773H409 Previous CUSIP: 45773H102 Exchange: NGS
Company's Online Profile
BUSINESS: Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV).
|
Notes: Jan. 23, 2024 -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that a 1-for-12 reverse stock split of its outstanding shares of common stock will be effective as of 5:00 p.m. Eastern Time on Wednesday, January 24, 2024. The company's common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on Thursday, January 25, 2024. Following the reverse stock split, the company's common stock will continue to trade on the Nasdaq Capital Market under the symbol "INO" with the new CUSIP number, 45773H 409. The reverse stock split is part of the company's plan to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.
|
Previous Ticker Symbol: GEB Changed: 4/04/2005
Previous Name: Genetronics Biomedical Ltd Changed: 5/17/2010
Small Cap Stock -
Market Value $ Million
Click for current INO price quote from the NASDAQ
|
Company's Online Information Links
|
| Company's Online Government Filings Links |
| Company's Email Address Links |
| Address and Phone Numbers |
| Address: 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462 |
| Main Phone Number |
267-440-4200 |
| Fax Number |
267-440-4242 |
| Investor Relations
Thomas Hong
|
267-440-4298
|
| Toll Free Phone Number |
877-446-6846 |
| CEO - Dr. J. Joseph Kim, PhD |
CFO - Peter Kies |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
